Financial Performance - The company's operating revenue for Q1 2017 was ¥1,080,094,509.29, representing a 1.23% increase compared to ¥1,066,966,889.88 in the same period last year[8] - Net profit attributable to shareholders was ¥66,285,000.20, a 22.86% increase from ¥53,950,416.00 year-on-year[8] - The net profit after deducting non-recurring gains and losses was ¥70,483,168.59, up 13.39% from ¥62,157,940.23 in the previous year[8] - Basic and diluted earnings per share decreased by 51.43% to ¥0.034 from ¥0.070 year-on-year[8] Cash Flow - The net cash flow from operating activities was -¥52,917,674.70, a decline of 87.11% compared to -¥28,281,433.24 in the same period last year[8] - Net cash flow from operating activities decreased by 87.11% compared to the same period last year, mainly due to increased cash payments for goods and services by the subsidiary Kaiyuan Commercial Co., Ltd.[16] - Net cash flow from investing activities decreased by 89.73% compared to the same period last year, primarily due to increased purchases of fixed assets and intangible assets by the subsidiary Shangluo International Medical Center[16] - Net cash flow from financing activities increased by 74.02% compared to the same period last year, mainly due to a decrease in the amount of loans repaid by the subsidiary in the commercial sector[16] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,468,354,237.50, down 1.57% from ¥5,555,314,848.21 at the end of the previous year[8] - Net assets attributable to shareholders increased by 1.90% to ¥3,553,690,343.48 from ¥3,487,418,672.53 at the end of the previous year[8] - Financial assets measured at fair value increased by 91.26% compared to the beginning of the year, primarily due to increased investments in fair value financial assets[16] - Prepayments increased by 38.79% compared to the beginning of the year, mainly due to increased engineering payments and land transfer fees by the subsidiary Xi'an High-tech Hospital[16] - Other current assets increased by 181.50% compared to the beginning of the year, primarily due to increased prepaid corporate income tax and VAT to be deducted by the subsidiary Kaiyuan Commercial Co., Ltd.[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 90,120[12] - The largest shareholder, Shaanxi Century New Yuan Commercial Management Co., Ltd., held 18.88% of the shares, totaling 372,093,150 shares[12] Corporate Actions - The company plans to transfer 100% equity of Kaiyuan Commercial Co., Ltd. to Wangfujing Group Co., Ltd., with the final transaction price to be determined through due diligence[17] - Independent financial advisors, lawyers, auditors, and evaluators have been appointed to conduct due diligence and audits related to the asset restructuring[17]
国际医学(000516) - 2017 Q1 - 季度财报